CEO / Assistant ProfessorSymphony Biosciences / Cornell UniversityIthaca, New York, United States
Disclosure information not submitted.
SymphNode Technology: Injectable Microparticles for Immune Modulation and Treatment of Triple-Negative Breast Cancer
Thursday, October 24, 20242:00 PM – 2:15 PM EST